India’s Biosimilar Boom: A New Opportunity for Pharma.
India’s pharmaceutical story has largely been built on generics. For decades, Indian companies have earned global recognition by making quality
India’s API Rise: Building a Stronger Pharma Supply Chain.
India’s pharmaceutical industry has built a global reputation for affordable medicines. But behind many of those medicines lies a supply
India’s GLP-1 Revolution: ₹15,700 Crore Opportunity.
By Ramesh Palav | Pharmaceutical Industry & Manufacturing Perspective For years, obesity was treated largely as a lifestyle problem. That
India’s Pharmaceutical Sector Enters Its Next Phase of Expansion
Executive Summary India’s pharmaceutical industry is entering a period in which growth will increasingly depend on capability rather than volume
Pharmaceutical Regulatory Audit & Inspection Status 2026.
Global Pharmaceutical GMP Inspection & Regulatory Compliance Analysis — Last 12 Months Analysis period: 7 September 2025 to 7 September
How to Search for Pharmaceuticals Jobs in India.
Last reviewed: September 2026 Finding the right pharma jobs in India requires more than uploading a CV to one job
Ozempic vs Wegovy vs Mounjaro: What’s the Difference?
Last reviewed: September 2026 Ozempic, Wegovy and Mounjaro have become some of the most discussed medicines in diabetes and obesity
GLP-1 Drugs Explained: How Do They Actually Cause Weight Loss?
GLP-1 drugs explained: These medicines have moved from being primarily associated with diabetes treatment to becoming one of the most
Indian Pharma Market Trends 2026–27: Opportunities, Challenges and Strategic Priorities.
Introduction: Indian Pharma Is Moving From Volume to Value For several decades, India’s pharmaceutical success story was built around a
GAMP 5: How to Apply Risk-Based Validation in the Pharmaceutical Industry.
When a pharmaceutical company implements a new LIMS, MES, ERP module, electronic document management system or cloud application, one question